New Rrpd Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-11-2024
- Paid Up Capital ₹ 0.10 M
as on 01-11-2024
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 01-11-2024
- Revenue 174.29%
(FY 2023)
- Profit -567.92%
(FY 2023)
- Ebitda 6.75%
(FY 2023)
- Net Worth -426.72%
(FY 2023)
- Total Assets 0.09%
(FY 2023)
About New Rrpd
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 Cr.
Sivakumar Narasimhan, Siddharth Upadhyay, and Karthik serve as directors at the Company.
- CIN/LLPIN
U51397TN2021PTC147584
- Company No.
147584
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2021
- Date of AGM
05 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at New Rrpd?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivakumar Narasimhan  | Whole-Time Director | 01-Nov-2021 | Current |
| Siddharth Upadhyay | Director | 25-Jul-2022 | Current |
| Karthik | Additional Director | 11-Jun-2024 | Current |
Financial Performance and Corporate Structure Insights of New Rrpd.
New Rrpd Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 174.29% increase. The company also saw a substantial fall in profitability, with a 567.92% decrease in profit. The company's net worth observed a substantial decline by a decrease of 426.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of New Rrpd?
In 2022, New Rrpd had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- New Siva Agencies Private LimitedActive 3 years 1 month
Sivakumar Narasimhan and Siddharth Upadhyay are mutual person
- Avenues Pharma Distributors Private LimitedActive 5 years 8 months
Siddharth Upadhyay is a mutual person
- City Pharma Distributors Private LimitedActive 3 years 9 months
Siddharth Upadhyay is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Jun 2023 | ₹5.00 Cr | Open |
How Many Employees Work at New Rrpd?
New Rrpd has a workforce of 29 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New Rrpd, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Rrpd's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
